KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Debt Ratio (2016 - 2025)

Alnylam Pharmaceuticals (ALNY) has disclosed Debt Ratio for 8 consecutive years, with 0.02 as the latest value for Q3 2025.

  • For Q3 2025, Debt Ratio changed N/A year-over-year to 0.02; the TTM value through Sep 2025 reached 0.02, changed N/A, while the annual FY2024 figure was 0.02, N/A changed from the prior year.
  • Debt Ratio hit 0.02 in Q3 2025 for Alnylam Pharmaceuticals, down from 0.03 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.19 in Q4 2021 and bottomed at 0.02 in Q4 2024.
  • Average Debt Ratio over 3 years is 0.06, with a median of 0.03 recorded in 2025.
  • On a YoY basis, Debt Ratio climbed as much as 230.35% in 2021 and fell as far as 230.35% in 2021.
  • Alnylam Pharmaceuticals' Debt Ratio stood at 0.19 in 2021, then tumbled by 88.07% to 0.02 in 2024, then grew by 12.99% to 0.02 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.02, 0.03, and 0.03 for Q3 2025, Q2 2025, and Q1 2025 respectively.